Fedratinib in Myelodysplastic /Myeloproliferative Neoplasms (MDS/MPNs) and Chronic Neutrophilic Leukemia (CNL)
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
Thomas Jefferson University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
M.D. Anderson Cancer Center
Barbara Ann Karmanos Cancer Institute
City of Hope Medical Center
Astex Pharmaceuticals, Inc.
University of Nebraska
Roswell Park Cancer Institute
Northwestern University
Fred Hutchinson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
OHSU Knight Cancer Institute
M.D. Anderson Cancer Center
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
Canadian Cancer Trials Group
University of Wisconsin, Madison
Roswell Park Cancer Institute
Children's Oncology Group
City of Hope Medical Center
Barbara Ann Karmanos Cancer Institute
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Wake Forest University Health Sciences
Wake Forest University Health Sciences
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
California Cancer Consortium
UNC Lineberger Comprehensive Cancer Center
Barbara Ann Karmanos Cancer Institute
Fred Hutchinson Cancer Center
Wake Forest University Health Sciences
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
OHSU Knight Cancer Institute
OHSU Knight Cancer Institute
University of Louisville
Fred Hutchinson Cancer Center
Vanderbilt-Ingram Cancer Center
Alliance for Clinical Trials in Oncology
Rutgers, The State University of New Jersey
Yale University
Barbara Ann Karmanos Cancer Institute
City of Hope Medical Center
City of Hope Medical Center